Drugs / Fosravuconazole
Fosravuconazole
also known as
Bms-379224 · E-1224 FREE ACID · Fosravuconazol · Ravuconazole methyl phosphate · Ravuconazole phosphoester
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT03086226 | May 2017 → Jun 2021 | mycetoma | Drugs for Neglected Diseases | Completed | Missed primary |
Press releases naming this drug 1 release
| Date | Issuer | Release |
|---|---|---|
| 2026-05-12 | Drugs for Neglected Diseases | DNDi welcomes GHIT support for global evaluation and registration of fosravuconazole for eumycetoma, in collaboration with Eisai dndi.org ↗ |
Evidence & citations 8 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Fosravuconazole | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03086226 ↗ |
| Known as | Bms-379224 | ChEMBL registry synonym — accepted as the source's own label CHEMBL333325 ↗ |
| Known as | E-1224 FREE ACID | ChEMBL registry synonym — accepted as the source's own label CHEMBL333325 ↗ |
| Known as | Fosravuconazol | ChEMBL registry synonym — accepted as the source's own label CHEMBL333325 ↗ |
| Known as | Ravuconazole methyl phosphate | ChEMBL registry synonym — accepted as the source's own label CHEMBL333325 ↗ |
| Known as | Ravuconazole phosphoester | ChEMBL registry synonym — accepted as the source's own label CHEMBL333325 ↗ |
| Modality | Small molecule | — CHEMBL333325 ↗ |
| Route | Oral | “oral fosravuconazole” PMID 40433693 ↗ Sep 2025 |